Skip to main content

Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

sivifene gel

The phenylhydrazone 4,4'-dihydroxybenzophenone-2,4-dinitrophenylhydrazone formulated as a topical agent with immunomodulating and potential antineoplastic activities. Applied topically as a gel, sivifene may stimulate a local immune response against human papillomavirus (HPV)-induced cervical intraepithelial neoplasia (CIN).

Check for active clinical trials using this agent View this agent in the NCI Thesaurus

Code name:	A-007
Chemical structure:	4,4'-[[2-(2,4-dinitrophenyl)hydrazinylidene]methylene]diphenol 4,4'-dihydroxybenzophenone-2,4-dinitrophenylhydrazone methanone, bis(4-hydroxyphenyl)-, (2,4-dinitrophenyl)hydrazone

sivifene gel

Search NCI's Drug Dictionary